Ludwig-Maximilians-Universität München

Munchen, Germany
Public university in Munich, Bavaria
Geschwister-Scholl-Platz 1, 80539 München

About Ludwig-Maximilians-Universität München


Ludwig Maximilian University of Munich is a public research university located in Munich, Germany. The University of Munich is Germany's sixth-oldest university in continuous operation.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Genentech, Inc.
2
German CLL Study Group
2
Ludwig-Maximilians - University of Munich
2
Lux Biosciences, Inc.
2
United Therapeutics
2
AB2 Bio Ltd.
1
Ariad Pharmaceuticals
1
Astellas Pharma Inc
1
Baxter Healthcare Corporation
1
Bioven Europe
1
Total Rows: 33

Clinical Trials at Ludwig-Maximilians-Universität München


During the past decade, Ludwig-Maximilians-Universität München conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22441122553300110011000011331111Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
2002-05-01
2005-03-01
Completed
612
Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
2002-06-01
2004-03-01
Completed
72
European Childhood Obesity Project: Early Programming by Infant Nutrition?
2002-10-01
2023-12-01
Active, not recruiting
1,678
Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk
2007-04-01
2010-11-01
Terminated
368
Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
2007-04-01
2010-01-01
Terminated
122
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
2007-12-01
2012-06-01
Completed
1,331
EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye
2002-09-01
Terminated
84
Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
2008-06-01
2020-09-01
Completed
330

Rows per page:

1–40 of 40

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Ludwig-Maximilians-Universität München" #1 sponsor was "Pfizer" with 3 trials, followed by "Genentech, Inc." with 2 trials sponsored, "German CLL Study Group" with 2 trials sponsored, "Ludwig-Maximilians - University of Munich" with 2 trials sponsored and "Lux Biosciences, Inc." with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 33 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ludwig-Maximilians-Universität München" #1 collaborator was "German Research Foundation" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "A.O. Ospedale Papa Giovanni XXIII" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Accelopment AG" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 3Pfizer: 3Genentech, Inc.: 2Genentech, Inc.: 2German CLL Study Group: 2German CLL Study Group: 2Ludwig-Maximilians -University of Munich: 2Ludwig-Maximilians -University of Munich: 2Lux Biosciences, Inc.: 2Lux Biosciences, Inc.: 2United Therapeutics: 2United Therapeutics: 2AB2 Bio Ltd.: 1AB2 Bio Ltd.: 1Ariad Pharmaceuticals: 1Ariad Pharmaceuticals: 1Astellas Pharma Inc: 1Astellas Pharma Inc: 1Baxter HealthcareCorporation: 1Baxter HealthcareCorporation: 1

Created with Highcharts 11.1.0Top CollaboratorsGerman Research Foundation: 2German Research Foundation: 2Pfizer: 2Pfizer: 2A.O. Ospedale PapaGiovanni XXIII: 1A.O. Ospedale PapaGiovanni XXIII: 1AbbVie: 1AbbVie: 1Accelopment AG: 1Accelopment AG: 1Apatech, Inc.: 1Apatech, Inc.: 1AstraZeneca: 1AstraZeneca: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1CORE BIOMARKERLABORATORY: FundatioHospital UniversitariVall d'Hebron, 08035Barcelona, Spain: 1CORE BIOMARKERLABORATORY: FundatioHospital UniversitariVall d'Hebron, 08035Barcelona, Spain: 1CORE IMAGINGLABORATORY: EppdataGmbH, 22529Hamburg, Germany: 1CORE IMAGINGLABORATORY: EppdataGmbH, 22529Hamburg, Germany: 1

Clinical Trials Conditions at Ludwig-Maximilians-Universität München


According to Clinical.Site data, the most researched conditions in "Ludwig-Maximilians-Universität München" are "Alzheimer's Disease" (3 trials), "Smoking Cessation" (3 trials), "Pulmonary Arterial Hypertension" (2 trials), "ALK-positive Advanced NSCLC" (1 trials) and "Acromegaly" (1 trials). Many other conditions were trialed in "Ludwig-Maximilians-Universität München" in a lesser frequency.

Clinical Trials Intervention Types at Ludwig-Maximilians-Universität München


Most popular intervention types in "Ludwig-Maximilians-Universität München" are "Drug" (26 trials), "Other" (8 trials), "Biological" (7 trials), "Procedure" (4 trials) and "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Bendamustine" (2 trials), "LX201" (2 trials), "Obinutuzumab" (2 trials) and "Venetoclax" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Ludwig-Maximilians-Universität München


The vast majority of trials in "Ludwig-Maximilians-Universität München" are 40 trials for "All" genders.

Clinical Trials Status at Ludwig-Maximilians-Universität München


Currently, there are NaN active trials in "Ludwig-Maximilians-Universität München". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Ludwig-Maximilians-Universität München, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Ludwig-Maximilians-Universität München, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 10Phase 2: 10Not Applicable: 6Not Applicable: 6Phase 4: 6Phase 4: 6Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 22Completed: 22Active, not recruiting: 7Active, not recruiting: 7Terminated: 6Terminated: 6Recruiting: 4Recruiting: 4Unknown status: 1Unknown status: 1